Loading...
Ardelyx Community
NasdaqGM:ARDX Community- 2 Narratives written by author
- 0 Comments on narratives written by author
- 110 Fair Values set on narratives written by author
Community Investing Ideas
Global Healthcare And Aging Trends Will Unleash Market Opportunity
Key Takeaways Expanding markets, better market access, and prescription growth are accelerating adoption of core therapies, supporting sustained revenue and margin improvement. International partnerships and new indications diversify revenue streams, mitigate risks, and enhance long-term earnings stability.Read more
0users have liked this narrative
0users have commented on this narrative
59users have followed this narrative
AN
US$11.73
n/aintrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
23.05% p.a.
Profit Margin
29.34%
Future PE
17.41x
Share price in 2028
US$14.45
Pricing And Regulation Risks Will Undercut Revenue Yet Yield Recovery
Key Takeaways Heavy reliance on a few key products leaves Ardelyx exposed to reimbursement challenges, pricing pressures, and strong competition in core therapeutic areas. Expanding regulatory scrutiny, rising compliance and R&D costs, and restricted drug market access threaten net margins and delay sustainable profitability.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$8
29.4% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
10.85% p.a.
Profit Margin
10.93%
Future PE
42.98x
Share price in 2028
US$9.74